Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-027207

Options or other derivatives

  • EVP, COO, Head of Commercial acquired 117,195 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Teehan Brendan EVP, COO, Head of Commercial 2023-05-01 Grant or award · Stock Options (Right to Buy) +89,936 89,936 D
Teehan Brendan EVP, COO, Head of Commercial 2023-05-01 Grant or award · Restricted Stock Units +27,259 27,259 D
Loading xslF345X04/doc4.xml…